Zobrazeno 1 - 10
of 1 155
pro vyhledávání: '"Loyal L"'
Autor:
Beck F; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany., Nguyen P; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany., Hoffmann A; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany., Loyal L; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Immunomics - Regenerative Immunology and Aging, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin; Berlin, Germany., Thiel A; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Immunomics - Regenerative Immunology and Aging, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin; Berlin, Germany., Melzer M; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany., Apel H; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany., Pierer M; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany., Krasselt M; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany., Seifert O; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany., Glimm AM; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany., Hagemann T; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany., Rothe K; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany., Wagner U; Department of Rheumatology, Medizinische Klinik III, Universität Leipzig, Medizinische Fakultät, Leipzig, Germany.
Publikováno v:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Jul 25. Date of Electronic Publication: 2024 Jul 25.
Autor:
Tranter E; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany., Frentsch M; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.; BIH Center for Regenerative Therapies, Berlin Institute of Health at Charité Universitätsmedizin Berlin, Berlin, Germany., Hütter-Krönke ML; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany., Vuong GL; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany., Busch D; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany., Loyal L; Si-M/'Der Simulierte Mensch', A Science Framework of Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.; BIH Center of Immunomics-Regenerative Immunology and Aging, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Henze L; Si-M/'Der Simulierte Mensch', A Science Framework of Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.; BIH Center of Immunomics-Regenerative Immunology and Aging, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Rosnev S; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany., Blau IW; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany., Thiel A; Si-M/'Der Simulierte Mensch', A Science Framework of Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.; BIH Center of Immunomics-Regenerative Immunology and Aging, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Beule D; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Bullinger L; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.; ECRC Experimental and Clinical Research Center, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany., Obermayer B; Core Unit Bioinformatics, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Na IK; Medizinische Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.; BIH Center for Regenerative Therapies, Berlin Institute of Health at Charité Universitätsmedizin Berlin, Berlin, Germany.; Si-M/'Der Simulierte Mensch', A Science Framework of Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.; ECRC Experimental and Clinical Research Center, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
Publikováno v:
Journal of medical virology [J Med Virol] 2024 Mar; Vol. 96 (3), pp. e29539.
Autor:
Wang M; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Dehlinger A; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Zapata CF; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Golan M; Neuroimmunology and Multiple Sclerosis Unit and Laboratory, Sourasky Medical Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Gallaccio G; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Sander LE; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Schlickeiser S; Institute of Medical Immunology, BIH Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, and Berlin Institute of Health Berlin, Berlin, Germany., Kunkel D; Flow&MassCytometry Core Facility, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Schmitz-Hübsch T; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Sawitzki B; Translational Immunology, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany., Karni A; Neuroimmunology and Multiple Sclerosis Unit and Laboratory, Sourasky Medical Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Faculty of Medicine and Sagol School of Neuroscience Tel Aviv University, Tel Aviv, Israel., Braun J; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Immunomics-Regenerative Immunology and Aging, Berlin, Germany., Loyal L; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Immunomics-Regenerative Immunology and Aging, Berlin, Germany., Thiel A; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Immunomics-Regenerative Immunology and Aging, Berlin, Germany., Bellmann-Strobl J; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Paul F; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Meyer-Arndt L; Neuroscience Clinical Research Center, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Böttcher C; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin Berlin, Berlin, Germany. chotima.boettcher@charite.de.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. chotima.boettcher@charite.de.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. chotima.boettcher@charite.de.
Publikováno v:
Nature communications [Nat Commun] 2023 Nov 25; Vol. 14 (1), pp. 7728. Date of Electronic Publication: 2023 Nov 25.
Publikováno v:
Gaming Law Review & Economics; Nov2016, Vol. 20 Issue 9, p797-800, 4p
Autor:
Obermayer B; Core Unit Bioinformatics (CUBI), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany., Keilholz L; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany., Conrad T; Core Unit Genomics, Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Frentsch M; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany., Blau IW; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Vuong L; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Stem Cell Facility, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Lesch S; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany., Movasshagi K; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Stem Cell Facility, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Tietze-Stolley C; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Stem Cell Facility, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Loyal L; BIH Center for Exploratory Diagnostic Sciences (EDS), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany.; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charite - Universitätsmedizin Berlin, Berlin, Germany.; Immunomics - Regenerative Immunology and Aging, Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany., Henze L; BIH Center for Exploratory Diagnostic Sciences (EDS), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany.; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charite - Universitätsmedizin Berlin, Berlin, Germany.; Immunomics - Regenerative Immunology and Aging, Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany., Penack O; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany., Stervbo U; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany.; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany., Babel N; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany.; Center for Translational Medicine and Immune Diagnostics Laboratory, Medical Department I, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany., Haas S; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; BIH Center for Exploratory Diagnostic Sciences (EDS), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Beule D; Core Unit Bioinformatics (CUBI), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany., Bullinger L; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; ECRC Experimental and Clinical Research Center, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Wittenbecher F; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany., Na IK; Department of Hematology, Oncology, and Tumor Immunology, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charite - Universitätsmedizin Berlin, Berlin, Germany.; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charite - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; ECRC Experimental and Clinical Research Center, Charite - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Feb 10; Vol. 14, pp. 1114368. Date of Electronic Publication: 2023 Feb 10 (Print Publication: 2023).
Autor:
Henze L; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Braun J; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Meyer-Arndt L; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Jürchott K; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Schlotz M; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Michel J; Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany., Grossegesse M; Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany., Mangold M; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Dingeldey M; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Kruse B; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Holenya P; JPT Peptide Technologies GmbH, Berlin, Germany., Mages N; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany.; Max Planck Institute for Molecular Genetics, Berlin, Germany., Reimer U; JPT Peptide Technologies GmbH, Berlin, Germany., Eckey M; JPT Peptide Technologies GmbH, Berlin, Germany., Schnatbaum K; JPT Peptide Technologies GmbH, Berlin, Germany., Wenschuh H; JPT Peptide Technologies GmbH, Berlin, Germany., Timmermann B; Max Planck Institute for Molecular Genetics, Berlin, Germany., Klein F; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner site Bonn-Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Nitsche A; Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany., Giesecke-Thiel C; Max Planck Institute for Molecular Genetics, Berlin, Germany., Loyal L; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany., Thiel A; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Regenerative Immunology and Aging, BIH Immunomics, Berlin Institute of Health, Berlin, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Jan 31; Vol. 14, pp. 1056525. Date of Electronic Publication: 2023 Jan 31 (Print Publication: 2023).
Autor:
Forkel H; Internal Medicine Clinic C, University Medicine Greifswald, Greifswald, Germany., Grabarczyk P; Internal Medicine Clinic C, University Medicine Greifswald, Greifswald, Germany., Depke M; Internal Medicine Clinic C, University Medicine Greifswald, Greifswald, Germany., Troschke-Meurer S; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Simm S; Institute of Bioinformatics, University Medicine Greifswald, Greifswald, Germany., Hammer E; Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany., Michalik S; Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany., Hentschker C; Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany., Corleis B; Institute for Immunology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Greifswald, Germany., Loyal L; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Zumpe M; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Siebert N; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Dorhoi A; Institute for Immunology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Greifswald, Germany., Thiel A; Si-M/'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Lode H; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Völker U; Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany., Schmidt CA; Internal Medicine Clinic C, University Medicine Greifswald, Greifswald, Germany.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2022 Dec 05; Vol. 11 (1), pp. 2148850. Date of Electronic Publication: 2022 Dec 05 (Print Publication: 2022).
Autor:
Meyer-Arndt L; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Braun J; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany., Fauchere F; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany., Vanshylla K; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Loyal L; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany., Henze L; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany., Kruse B; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany., Dingeldey M; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany., Jürchott K; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany., Mangold M; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Maraj A; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Braginets A; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Böttcher C; Department of Neuropsychiatry, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Nitsche A; Robert Koch Institute, Berlin, Germany., de la Rosa K; Department of Cancer and Immunology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Ratswohl C; Department of Cancer and Immunology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Sawitzki B; Berlin Institute of Health (BIH), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Institute for Medical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Holenya P; JPT Peptide Technologies, Berlin, Germany., Reimer U; JPT Peptide Technologies, Berlin, Germany., Sander LE; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Klein F; Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; German Center for Infection Research (DZIF), Partner site Bonn-Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany., Paul F; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Bellmann-Strobl J; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany., Thiel A; Regenerative Immunology and Aging, BIH Immunomics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Si-M / 'Der Simulierte Mensch' a science framework of Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany., Giesecke-Thiel C; Max Planck Institute for Molecular Genetics, Berlin, Germany giesecke@molgen.mpg.de.
Publikováno v:
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2022 Sep; Vol. 93 (9), pp. 960-971. Date of Electronic Publication: 2022 Jul 14.
Autor:
Meyer-Arndt L; Si-M/'Der Simulierte Mensch', Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berliner Institut für Gesundheitsforschung, Immunomics, Regenerative Immunologie und Altern, Berlin, Germany.; Charité - Universitätsmedizin Berlin, NeuroCure Clinical Research Center, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Klinik für Neurologie mit Experimenteller Neurologie, Berlin, Germany.; Charité - Universitätsmedizin Berlin and Max-Delbrück-Centrum für Molekulare Medizin, Experimental and Clinical Research Center, Berlin, Germany., Schwarz T; Charité - Universitätsmedizin Berlin, Institut für Virologie, Berlin, Germany., Loyal L; Si-M/'Der Simulierte Mensch', Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berliner Institut für Gesundheitsforschung, Immunomics, Regenerative Immunologie und Altern, Berlin, Germany., Henze L; Si-M/'Der Simulierte Mensch', Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berliner Institut für Gesundheitsforschung, Immunomics, Regenerative Immunologie und Altern, Berlin, Germany., Kruse B; Si-M/'Der Simulierte Mensch', Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berliner Institut für Gesundheitsforschung, Immunomics, Regenerative Immunologie und Altern, Berlin, Germany., Dingeldey M; Si-M/'Der Simulierte Mensch', Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berliner Institut für Gesundheitsforschung, Immunomics, Regenerative Immunologie und Altern, Berlin, Germany., Gürcan K; Medizinische Biotechnologie, Institut für Biotechnologie, Technische Universität Berlin, Berlin, Germany., Uyar-Aydin Z; Medizinische Biotechnologie, Institut für Biotechnologie, Technische Universität Berlin, Berlin, Germany., Müller MA; Charité - Universitätsmedizin Berlin, Institut für Virologie, Berlin, Germany., Drosten C; Charité - Universitätsmedizin Berlin, Institut für Virologie, Berlin, Germany., Paul F; Charité - Universitätsmedizin Berlin, Berliner Institut für Gesundheitsforschung, Immunomics, Regenerative Immunologie und Altern, Berlin, Germany.; Charité - Universitätsmedizin Berlin and Max-Delbrück-Centrum für Molekulare Medizin, Experimental and Clinical Research Center, Berlin, Germany., Sander LE; Charité - Universitätsmedizin Berlin, Klinik für Infektiologie und Pneumologie, Berlin, Germany., Demuth I; Charité - Universitätsmedizin Berlin, Klinik für Endokrinologie und Stoffwechselmedizin, Biologie des Alterns, Berlin, Germany.; Berliner Institut für Gesundheitsforschung der Charité - Universitätsmedizin Berlin, Centrum für Regenerative Therapien, Berlin, Germany; and., Lauster R; Medizinische Biotechnologie, Institut für Biotechnologie, Technische Universität Berlin, Berlin, Germany., Giesecke-Thiel C; Max Planck Institute for Molecular Genetics, Berlin, Germany., Braun J; Si-M/'Der Simulierte Mensch', Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berliner Institut für Gesundheitsforschung, Immunomics, Regenerative Immunologie und Altern, Berlin, Germany., Corman VM; Charité - Universitätsmedizin Berlin, Institut für Virologie, Berlin, Germany; andreas.thiel@charite.de victor.corman@charite.de., Thiel A; Si-M/'Der Simulierte Mensch', Technische Universität Berlin and Charité - Universitätsmedizin Berlin, Berlin, Germany; andreas.thiel@charite.de victor.corman@charite.de.; Charité - Universitätsmedizin Berlin, Berliner Institut für Gesundheitsforschung, Immunomics, Regenerative Immunologie und Altern, Berlin, Germany.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2022 Mar 01; Vol. 208 (5), pp. 1001-1005. Date of Electronic Publication: 2022 Feb 04.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.